Vir Biotechnology, Inc. (VIR) Financials
VIR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 1.8 billion | 246.6 million |
2023-12-31 | 2.0 billion | 369.9 million |
2023-09-30 | 2.0 billion | 369.8 million |
2023-06-30 | 2.2 billion | 433.7 million |
VIR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -111.3 million | ? |
2023-12-31 | -109.5 million | 28.3 million |
2023-09-30 | -159.5 million | 26.9 million |
2023-06-30 | -398.7 million | 30.6 million |
VIR Net Income
No data available :(
VIR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 1.2 billion | - | - |
2023-12-31 | 1.5 billion | - | 124.5 million |
2023-09-30 | 1.7 billion | - | 114.1 million |
2023-06-30 | 1.8 billion | - | 117.8 million |
VIR Shares Outstanding
VIR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 1.9 million | 100.1 million | - | - |
2023-12-31 | 1.5 million | 89.5 million | 43.1 million | - |
2023-09-30 | 3.7 million | 148.3 million | 41.1 million | - |
2023-06-30 | 9.5 million | 171.9 million | 47.1 million | - |
VIR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 56.4 million | 59000 |
2023-12-31 | 16.8 million | 5.3 million |
2023-09-30 | -4.1 million | 38000 |
2023-06-30 | -12.7 million | 22000 |
VIR
Price: $10.39
52 week price:
Earnings Per Share: -4.59 USD
P/E Ratio: -1.91
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 703157
Market Capitalization: 1.4 billion